| pubmed-article:14521169 | pubmed:abstractText | Beta2m accumulation induces disease in patients with end-stage renal failure (ESRF). Thus, its removal from patients with ESRF appears desirable. Current dialysis technology, however, has limited effectiveness. | lld:pubmed |
